Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.creatorHernangómez, Miriam-
dc.creatorCarrillo Salinas, Francisco-
dc.creatorMecha, Miriam-
dc.creatorCorrea, Fernando Gabriel-
dc.creatorMestre, Leyre-
dc.creatorLoría, Frida-
dc.creatorFeliú, Ana-
dc.creatorDocagne, Fabian-
dc.creatorGuaza, Carmen-
dc.date2017-03-07T18:59:33Z-
dc.date2017-03-07T18:59:33Z-
dc.date2014-01-
dc.date2017-03-06T15:25:40Z-
dc.date.accessioned2019-04-29T15:41:47Z-
dc.date.available2019-04-29T15:41:47Z-
dc.date.issued2014-01-
dc.identifierHernangómez, Miriam; Carrillo Salinas, Francisco; Mecha, Miriam; Correa, Fernando Gabriel; Mestre, Leyre; et al.; Brain innate immunity in the regulation of neuroinflammation: therapeutic strategies by modulating cd200-cd200r interaction involve the cannabinoid system; Bentham Science Publishers; Current Pharmaceutical Design.; 20; 29; 1-2014; 4707-4722-
dc.identifier1381-6128-
dc.identifierhttp://hdl.handle.net/11336/13598-
dc.identifier1873-4286-
dc.identifier.urihttp://rodna.bn.gov.ar:8080/jspui/handle/bnmm/299775-
dc.descriptionThe central nervous system (CNS) innate immune response includes an arsenal of molecules and receptors expressed by professional phagocytes, glial cells and neurons that is involved in host defence and clearance of toxic and dangerous cell debris. However, any uncontrolled innate immune responses within the CNS are widely recognized as playing a major role in the development of autoimmune disorders and neurodegeneration, with multiple sclerosis (MS) and Alzheimer´s disease (AD) being primary examples. Hence, it is important to identify the key regulatory mechanisms involved in the control of CNS innate immunity and which could be harnessed to explore novel therapeutic avenues. Neuroimmune regulatory proteins (NIReg) such as CD95L, CD200, CD47, sialic acid, complement regulatory proteins (CD55, CD46, fH, C3a), HMGB1, may control the adverse immune responses in health and diseases. In the absence of these regulators, when neurons die by apoptosis, become infected or damaged, microglia and infiltrating immune cells are free to cause injury as well as an adverse inflammatory response in acute and chronic settings. We will herein provide new emphasis on the role of the pair CD200-CD200R in MS and its experimental models: experimental autoimmune encephalomyelitis (EAE) and Theiler?s virus induced demyelinating disease (TMEV-IDD). The interest of the cannabinoid system as inhibitor of inflammation prompt us to introduce our findings about the role of endocannabinoids (eCBs) in promoting CD200-CD200 receptor (CD200R) interaction and the benefits caused in TMEV-IDD. Finally, we also review the current data on CD200-CD200R interaction in AD, as well as, in the aging brain.-
dc.descriptionFil: Hernangómez, Miriam. Consejo Superior de Investigaciones Cientificas; España-
dc.descriptionFil: Carrillo Salinas, Francisco. Consejo Superior de Investigaciones Cientificas; España-
dc.descriptionFil: Mecha, Miriam. Consejo Superior de Investigaciones Cientificas; España-
dc.descriptionFil: Correa, Fernando Gabriel. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Centro de Estudios Farmacológicos y Botánicos; Argentina. Universidad de Buenos Aires. Facultad de Medicina; Argentina-
dc.descriptionFil: Mestre, Leyre. Consejo Superior de Investigaciones Cientificas; España-
dc.descriptionFil: Loría, Frida. Consejo Superior de Investigaciones Cientificas; España-
dc.descriptionFil: Feliú, Ana. Consejo Superior de Investigaciones Cientificas; España-
dc.descriptionFil: Docagne, Fabian. Inserm; Francia-
dc.descriptionFil: Guaza, Carmen. Consejo Superior de Investigaciones Cientificas; España-
dc.formatapplication/pdf-
dc.formatapplication/pdf-
dc.languageeng-
dc.publisherBentham Science Publishers-
dc.relationinfo:eu-repo/semantics/altIdentifier/url/http://www.eurekaselect.com/120067/article-
dc.relationinfo:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.2174/1381612820666140130202911-
dc.relationinfo:eu-repo/semantics/altIdentifier/url/https://www.ncbi.nlm.nih.gov/pubmed/24588829-
dc.rightsinfo:eu-repo/semantics/restrictedAccess-
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/2.5/ar/-
dc.sourcereponame:CONICET Digital (CONICET)-
dc.sourceinstname:Consejo Nacional de Investigaciones Científicas y Técnicas-
dc.sourceinstacron:CONICET-
dc.subjectneuroinflammation-
dc.subjectmicroglia-
dc.subjectneurons-
dc.subjectneuroimmunoregulatory molecules-
dc.subjectCD200-
dc.subjectCD200R-
dc.subjectmultiple sclerosis-
dc.subjectaging brain-
dc.subjectAlzheimer’s disease-
dc.subjectcannabinoids-
dc.subjectNeurociencias-
dc.subjectMedicina Básica-
dc.subjectCIENCIAS MÉDICAS Y DE LA SALUD-
dc.titleBrain innate immunity in the regulation of neuroinflammation: therapeutic strategies by modulating cd200-cd200r interaction involve the cannabinoid system-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.typeinfo:ar-repo/semantics/articulo-
Aparece en las colecciones: CONICET

Ficheros en este ítem:
No hay ficheros asociados a este ítem.